Related Experiment Video
Updated: Aug 4, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Anti-carcinogenic activity of Taraxacum plant. II
M Takasaki1, T Konoshima, H Tokuda
1Kyoto Pharmaceutical University, Japan.
Abstract:
Eleven triterpenoids (1-11) from the roots of Taraxacum japonicum (Compositae) were examined for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) induced by the tumor promoter, 12-O-tetrade-canoylphorbol-13-acetate (TPA), in Raji cells as a primary screening test for anti-tumor-promoters (cancer chemopreventive agents). Of these triterpenoids, taraxasterol (1) and taraxerol (7) exhibited significant inhibitory effects on EBV-EA induction, but the inhibitory effects of their acetates 2 and 8 were weaker than those of 1 and 7. Furthermore, 1 and 7 exhibited potent anti-tumor-promoting activity in the two-stage carcinogenesis tests of mouse skin using 7,12-dimethylbenz[a]anthracene (DMBA) as an initiator and TPA as a promoter, and 1 showed a remarkable inhibitory effect on mouse spontaneous mammary tumors using C3H/OuJ mouse. These results strongly suggested that taraxasterol (1) could be a valuable chemopreventive agent.
Insights
Taraxasterol and taraxerol from Taraxacum japonicum roots show promise as cancer chemopreventive agents. These compounds effectively inhibited tumor promotion in mouse models, suggesting potential for cancer prevention.
Area of Science:
- Natural Product Chemistry
- Cancer Chemoprevention Research
- Pharmacology
Background:
- Natural products are a rich source of potential therapeutic agents.
- Triterpenoids from Taraxacum species have demonstrated various biological activities.
- Identifying novel cancer chemopreventive agents is crucial for public health.
Purpose of the Study:
- To investigate the anti-tumor-promoting potential of triterpenoids isolated from Taraxacum japonicum roots.
- To evaluate the inhibitory effects of these compounds on Epstein-Barr virus early antigen (EBV-EA) induction.
- To assess the efficacy of selected triterpenoids in animal models of carcinogenesis.
Main Methods:
- Eleven triterpenoids were isolated from Taraxacum japonicum roots.
- In vitro screening involved assessing inhibition of EBV-EA induction by 12-O-tetrade-canoylphorbol-13-acetate (TPA) in Raji cells.
- In vivo studies included two-stage mouse skin carcinogenesis tests and evaluation of spontaneous mammary tumors in mice.
Main Results:
- Taraxasterol (1) and taraxerol (7) demonstrated significant inhibition of EBV-EA induction.
- Acetates 2 and 8 showed weaker inhibitory effects compared to compounds 1 and 7.
- Taraxasterol (1) and taraxerol (7) exhibited potent anti-tumor-promoting activity in mouse skin carcinogenesis.
- Taraxasterol (1) showed a remarkable inhibitory effect on spontaneous mammary tumors in C3H/OuJ mice.
Conclusions:
- Taraxasterol (1) and taraxerol (7) possess significant anti-tumor-promoting properties.
- Taraxasterol (1) shows particular promise as a chemopreventive agent against various cancers.
- Further research into Taraxacum japonicum-derived triterpenoids is warranted for cancer prevention strategies.
Related Concept Videos
Physical Properties of Amines
Mutagenicity and Carcinogenicity

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)